Khan SU, Ul Abideen, Asad Z, et al. Aspirin for primary prevention of cardiovascular outcomes in diabetes mellitus: An updated systematic review and meta-analysis. Eur J Prev Cardiol. Epub ahead of print 30 January 2019. DOI: 10.1177/2047487319825510.
2.
SnydermanRMeadeCDrakeC. Value of personalized medicine. JAMA2016; 315: 613–613.
3.
AntmanEMLoscalzoJ. Precision medicine in cardiology. Nat Rev Cardiol2016; 13: 591–602.
4.
LeggioMBendiniMGCaldaroneE, et al.Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?Diabetes Metab2018; 44: 217–225.
